期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

免疫性血小板减少症的免疫异常特征与治疗进展 被引量：4

Progress of the Immune Dysfunction and Treatment of Immune Thrombocytopenia
下载PDF
导出
摘要 免疫性血小板减少症（immune thrombocytopenia,ITP）是一种由体液免疫和细胞免疫异常导致血小板破坏增多、生成减少、临床上以皮肤黏膜出血为特征的血小板减少性疾病[1],成人发病率约为5～10/10万[2],儿童年发病率为1.9～6.4/10万[3].自身抗体介导的血小板破坏是ITP的发病基础.自身抗体使ITP患者的血小板仅存在数小时就会被迅速清除,远远短于正常人血小板寿命.
作者 闪丹 顾健
机构地区 徐州医学院 扬州大学临床医学院
出处 《血栓与止血学》 2013年第6期283-287,共5页 Chinese Journal of Thrombosis and Hemostasis
关键词 免疫性血小板减少症 免疫异常 治疗
分类号 R558 [医药卫生—血液循环系统疾病]
  • 相关文献

参考文献50

  • 1STASI R,EVANGELISTA ML,STIPA E ,et al. Idiopathic thrombocy- topenic purpura:Current concepts in pathophysiology and management [J]. Thromb Haemost,2008, 99( 1 ) :4-13. 被引量：1
  • 2PROVAN D ,STASI R, NEWLAND AC, et al. International consensus report on the investigation and management of primary immune throm- bocytopenia[ J]. Blood,2010,115 (2) : 168-186. 被引量：1
  • 3TERRELL DR, BEEBE LA, VESELY SK, et al. The incidence of im- mune thromboeytopenic purpura in children and adults:a critical re- view of published reports[ J]. Am J Hematol, 2010,85:174-180. 被引量：1
  • 4NEUNERT C, LIM W, CROWTHER M, et al. The American society of hematology 2011 evidence-based practice guideline for immune throm- bocytopenia[ J ]. Blood. 2011, 117 (16) :4190-4207. 被引量：1
  • 5RODEGHIERO F,STASI R, GERNSHEIMER T, t al. Standardization of terminology definitions and outcome criteria in immune thrombocy- topenic purpura of adults and children: report from an international working group[ J]. Blood, 2009,113 ( 11 ) : 2386-2393. 被引量：1
  • 6Van LEEUWEN EF, van der VEN JT, ENGELFRIET CP, et al. Specifi city of autoantibodies in autoimmune thrombocytopenia [ J ]. Blood,1982,59(1 ) : 23-26. 被引量：1
  • 7SCI-INEIDER P,MACKAY F,STEINER V,et al. BAFF, a novel lig- and of the tumor necrosis factor family, stimulates B cell growth[ J]. Exp Med, 1999,189 ( 11 ) : 1747 - 1756. 被引量：1
  • 8EMMERICI-I F, BAL G, BARAKAT A, et al. High- level serum B cell activating factor and promoter plolymorphismsims in patients with idio- pathic thrombocytopenic purpura [ J ]. Br J Heamatol, 2007,136 : 309- 314. 被引量：1
  • 9MCMILLAN R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura[ J ]. Semin Hematol,2000,37 (3) : 239- 248. 被引量：1
  • 10ZHOU B,ZHAO H, YANG RC, et al. Multi-dysfunctional pathophysi- ology in ITP[ J]. Crit Rev Oncol Hemato1,2005,54 (2) : 107-116. 被引量：1

二级参考文献8

  • 1GARCIA- CHAVEZ J, MAJLUF-Cruz A, MONTIEL-Cervantes L, et al. Rituximab therapy for chronic and refractory immune thrombocytopenic purpura : a long- term followup analysis [ J ]. Ann Hematol, 2007, 86(12) :871-877. 被引量：1
  • 2TANAKA Y. B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases [J]. Yakugaku Zasshi, 2009,129 ( 6 ) : 675- 679. 被引量：1
  • 3ZHOU X, HU W, QIN X. The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy [ J ]. Oncologist, 2008,13 (9) :954-966. 被引量：1
  • 4PEROTYA A, SUNNEBERG TA, SCOTF J, et al. Rituximab in the treatment of chronic idiopathic thrombocytopenic purpura[ J]. Blood, 1999,94:49a. 被引量：1
  • 5SALEH MN, GUTHEIL J, MOORE M, et al. A pilot study of the antiCD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia[ J]. Semin Oncol,2000,27(Suppl 12):99- 103. 被引量：1
  • 6KELLY K, GLEESON M, MURPHY PT, et al. Slow responses to standard dose rituximab in immune thrombocytopenie purpura [ J ]. Haematologica, 2009,94 ( 3 ) :443-444. 被引量：1
  • 7Drachman JG.Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood . 2004 被引量：1
  • 8隋涛,薛峰,赵海丰,葛菁,周虎,张磊,白洁,杨仁池.小剂量利妥昔单抗治疗慢性特发性血小板减少性紫癜疗效分析[J].中华血液学杂志,2010,31(3):161-163. 被引量：42

共引文献21

同被引文献32

  • 1赵天群,肖春玲,符林琴.慢性乙型肝炎患者健康教育指导效果观察和护理[J].护士进修杂志,2005,20(5):425-426. 被引量：26
  • 2季新燕,温耀明,陈振伟,郑卫.环孢素的生物学活性及其衍生物的研究进展[J].国外医药（抗生素分册）,2006,27(3):116-121. 被引量：11
  • 3Provan D,Stasi R,Newland AC,et al.International consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood,2010,115 (2):168-86. 被引量：1
  • 4Neunert C,Lim W,Crowther M,et al.The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J].Blood,2011,117 (16):4190-207. 被引量：1
  • 5Cines DB,Bussel JB,Liebman HA,et al.The ITP syndrome:pathogenic and clinical diversity[J].Blood,2009,113 (26):6511-6521. 被引量：1
  • 6Beck CE,Nathan PC,Parkin PC,et al.Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children:asystematic review and meta-analysi of randomized controlled trials[J].Pediatric,2008,147 (4):521-527. 被引量：1
  • 7Dolff S,Abdulahad WH,Bijl M,et al.Regulators of B-cell activity in SLE:a better target for treatment than B-cell depletion[J].Lupus,2009,18 (7):575-580. 被引量：1
  • 8Passweg JR,Rabusin M.Hematopoietic stem celltransplantation for immune thrombocytopenia and other refractory autoimmune cytopenias[J].Autoimmunity,2008,41(8):660-665. 被引量：1
  • 9Boruchov DM,Gururangan S,Driscoll MC,et al.Multiagent induction and maintenance therapy for patients with refractoryimmune thrombocytopenic purpura (ITP)[J].Blood,2007,110 (10):3526-3531. 被引量：1
  • 10RussoG,MiragliaV,Branciforte F,et al.Effect of eradication of helicobacter pylori in children with chronic immune thrombocytopenia:a prospective,controlled,multi-center study[J].Pediatr Blood Cancer,2011,56(2):273-278. 被引量：1

引证文献4

二级引证文献7

血栓与止血学
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部